Eun Su Choi

Title: The Innovative Contributions of Eun Su Choi

Introduction

Eun Su Choi is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biotechnology, particularly in cancer treatment. Her innovative work has led to the development of a novel antibody that has the potential to revolutionize cancer therapies.

Latest Patents

Eun Su Choi holds a patent for an "Anti-c-Met antibody and use thereof." This invention relates to a unique antibody or an antigen binding fragment that specifically binds to the human hepatocyte growth factor receptor (c-Met). The composition is designed for preventing or treating cancer, demonstrating excellent cancer cell proliferation inhibitory activity and remarkable anticancer effects, even in minimal amounts. This advancement holds promise for effective cancer prevention and treatment.

Career Highlights

Eun Su Choi is associated with Chong Kun Dang Pharmaceutical Corporation, where she continues to work on groundbreaking research and development in the pharmaceutical industry. Her dedication to innovation has positioned her as a key figure in her field.

Collaborations

Eun Su Choi collaborates with notable colleagues, including Ki Young An and Kyung Woo Lee. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Eun Su Choi's innovative work in developing an anti-c-Met antibody showcases her commitment to improving cancer therapies. Her contributions are paving the way for more effective treatments, highlighting the importance of innovation in the medical field.